The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses
GLP-1 RAs positively affect cognitive function in AD patients with T2DM. However, their efficacy on disparate cognitive domains requires further replication in larger scale controlled clinical trials.
Authors
- Hana Ballum (ORCID: https://orcid.org/0009-0005-4064-5588)
- Sonya Liao
- Christine E. Dri
- Gia Han Le
- Kayla M. Teopiz
- Hayun Choi
- Heidi K.Y.Lo
- Minyi Yu
- Roger S. McIntyre
- Maj Vinberg
- Joshua D. Rosenblat
- Angela T.H. Kwan
- Roger Ho
- Sabrina Wong
Institutions
- Chinese University of Hong Kong (HK)
- University of Toronto (CA)
- Hong Kong University of Science and Technology (HK)
- Brain and Cognition Discovery Foundation (CA)
- Capital Region of Denmark (DK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1016/j.jad.2026.121310
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00